Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Zarrabi

Showing results (261-270 of 302) with videos related to

Pageof 31
Sort By:
Phytotherapy Research : PTR|October 26, 2021
Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effectsAsal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady, et al.
International Journal of Biological Macromolecules|March 4, 2021
The role of SOX family transcription factors in gastric cancerAsal Jalal Abadi, Ali Zarrabi, Farid Hashemi, et al.
International Journal of Biological Macromolecules|October 3, 2022
Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistanceMehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 23, 2022
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic responseMilad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, et al.
Life Sciences|March 8, 2022
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapyMahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.
Life Sciences|March 31, 2021
Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapySepideh Mirzaei, Mohammad Hossein Gholami, Farid Hashemi, et al.
Medicinal Research Reviews|May 11, 2023
(Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapyMilad Ashrafizadeh, Ali Zarrabi, Ashkan Bigham, et al.
Pharmacological Research|July 10, 2021
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancerSepideh Mirzaei, Mohammad Hossein Gholami, Amirhossein Zabolian, et al.
Non-Coding RNA Research|December 11, 2023
Non-coding RNA-Mediated N6-Methyladenosine (m<sup>6</sup>A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy responseMehrdad Hashemi, Pouria Daneii, Mohammad Arad Zandieh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 15, 2021
Chitosan: A versatile bio-platform for breast cancer theranosticsVijay Sagar Madamsetty, Shima Tavakol, Saeid Moghassemi, et al.
Pageof 31

Showing results (261-270 of 302) with videos related to

Sort By:
Pageof 31
Phytotherapy Research : PTR|October 26, 2021
Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effectsAsal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady, et al.
International Journal of Biological Macromolecules|March 4, 2021
The role of SOX family transcription factors in gastric cancerAsal Jalal Abadi, Ali Zarrabi, Farid Hashemi, et al.
International Journal of Biological Macromolecules|October 3, 2022
Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistanceMehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 23, 2022
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic responseMilad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, et al.
Life Sciences|March 8, 2022
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapyMahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.
Life Sciences|March 31, 2021
Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapySepideh Mirzaei, Mohammad Hossein Gholami, Farid Hashemi, et al.
Medicinal Research Reviews|May 11, 2023
(Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapyMilad Ashrafizadeh, Ali Zarrabi, Ashkan Bigham, et al.
Pharmacological Research|July 10, 2021
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancerSepideh Mirzaei, Mohammad Hossein Gholami, Amirhossein Zabolian, et al.
Non-Coding RNA Research|December 11, 2023
Non-coding RNA-Mediated N6-Methyladenosine (m<sup>6</sup>A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy responseMehrdad Hashemi, Pouria Daneii, Mohammad Arad Zandieh, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 15, 2021
Chitosan: A versatile bio-platform for breast cancer theranosticsVijay Sagar Madamsetty, Shima Tavakol, Saeid Moghassemi, et al.
Pageof 31